The global Southern Blotting Market Growth Accelerated by Increasing Prevalence of Chronic Diseases

Southern blotting is a molecular biological technique used to detect the presence of a particular DNA sequence within genomic DNA. It has applications in biomedical research and medical diagnosis of chronic diseases. The technique relies on DNA fragments being separated by gel electrophoresis, then transferred and bound to a membrane, where they are detected through hybridization with a complementary Probe. This allows detection of specific genes, DNA, or RNA fragments separated in a DNA gel.

The global Southern Blotting Market is estimated to be valued at US$ 3.23 Billion in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing prevalence of chronic diseases is driving growth in the southern blotting market. Chronic diseases such as cancer require extensive research and diagnosis. Southern blotting helps researchers identify biomarkers and genetic factors associated with various types of cancer. It assists in mapping genes, detecting diseases, and developing personalized treatment options. The technique is therefore seeing increased usage in cancer research. Furthermore, rising cases of genetic disorders also boost demand for southern blotting as it allows researchers to characterize genes and mutations associated with genetic conditions. As the incidence of chronic diseases continues to rise globally due to rapidly aging populations and changing lifestyles, the application of southern blotting in disease research and diagnosis will likely increase over the forecast period.

Segment Analysis
Southern Blotting Market is segmented into product, technology, application, and end-user. The product segment is further divided into instruments, reagents & kits, and accessories & consumables. Reagents & kits dominates the product segment and accounts for more than 60% of the total southern blotting market share. Reagents & kits are important consumables used in southern blotting procedure and its high demand and repeat purchase drives the growth of this segment.

Key Takeaways
The Global Southern Blotting Market Size is expected to witness high growth over the forecast period of 2024 to 2031. The market is projected to grow at a CAGR of 6.8% during the forecast period. By 2031, the market size is estimated to reach US$ 5.55 Bn.

Regional analysis
North America accounted for the largest share of the southern blotting market in 2024 and is expected to maintain dominance over the forecast period. High prevalence of infectious diseases and presence of advanced research infrastructure in the region drives the growth. Asia Pacific exhibits the fastest growth and is expected to witness a CAGR of around 8% during the forecast period due to increasing R&D expenditure, high prevalence of target diseases, and growing biotechnology industry.

Key players
Key players operating in the Southern Blotting market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. Ganeden dominates the probiotic ingredients market. Sabinsa Corporation specializes in herbal active ingredients and biotherapeutics.

Get more insights on this topic:
https://www.dailyprbulletin.com/southern-blotting-market-regional/